Market Research Logo

United States Clinical Chemistry Market Outlook to 2024

United States Clinical Chemistry Market Outlook to 2024

Summary

GlobalData’s new report, United States Clinical Chemistry Market Outlook to 2024, provides key market data on the United States Clinical Chemistry market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Blood Test Strips - Rapid Tests & POC, Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Electrolyte Chemistry Reagents, Enzyme Chemistry Reagents, Feces Tests - Rapid Tests & POC, Metabolite Chemistry Reagents, Substrates, Therapeutic Drug Monitoring, Urine Analysis and Urine Testing - Rapid Tests & POC.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Clinical Chemistry market segments - Blood Test Strips - Rapid Tests & POC, Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Electrolyte Chemistry Reagents, Enzyme Chemistry Reagents, Feces Tests - Rapid Tests & POC, Metabolite Chemistry Reagents, Substrates, Therapeutic Drug Monitoring, Urine Analysis and Urine Testing - Rapid Tests & POC.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
  • 2017 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the United States Clinical Chemistry market.
  • Key players covered include F. Hoffmann-La Roche Ltd, Abbott Laboratories and Ortho-Clinical Diagnostics Inc.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Clinical Chemistry Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Clinical Chemistry Market, United States
3.1 Clinical Chemistry Market, United States, Revenue ($m), 2010-2017
3.2 Clinical Chemistry Market, United States, Revenue ($m), 2017-2024
3.3 Clinical Chemistry Market, United States, Volume (Units), 2010-2017
3.4 Clinical Chemistry Market, United States, Volume (Units), 2017-2024
3.5 Clinical Chemistry Market, United States, Average Price ($), 2010-2024
3.6 Clinical Chemistry Market, United States, Distribution Share by Revenue ($m), 2017
3.7 Clinical Chemistry Market, United States, Company Share by Revenue ($m), 2017
4 Overview of Key Companies in United States, Clinical Chemistry Market
4.1 F. Hoffmann-La Roche Ltd
4.2 Abbott Laboratories
4.3 Ortho-Clinical Diagnostics Inc
4.4 Siemens Healthcare GmbH
4.5 Beckman Coulter Inc
4.6 Meridian Bioscience Inc
4.7 Thermo Fisher Scientific Inc
4.8 Mindray Medical International Ltd
4.9 Randox Laboratories Ltd
4.10 Hitachi Ltd
4.11 Orion Diagnostica Oy
5 Clinical Chemistry Market Pipeline Products
6 Financial Deals Landscape
6.1 Acquisition
6.2 Debt Offerings
6.3 Equity Offerings
6.4 Private Equity
6.5 Venture Financing
7 Recent Developments
7.1 Corporate Communications
7.2 Financial Announcements
7.3 Government and Public Interest
7.4 Legal And Regulatory
7.5 Other Significant Developments
7.6 Product News
7.7 Research And Development
7.8 Strategy And Business Planning
8 Appendix
8.1 Research Methodology
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer
1.1 List of Tables
Table 1: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Table 2: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Table 3: Blood Test Strips - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Table 4: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Table 5: Enzyme Chemistry Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Table 6: Feces Tests - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Table 7: Substrates Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Table 8: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Table 9: Urine Analysis Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Table 10: Urine Testing - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Table 11: Blood Test Strips - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Table 12: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Table 13: Enzyme Chemistry Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Table 14: Feces Tests - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Table 15: Substrates Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Table 16: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Table 17: Urine Analysis Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Table 18: Urine Testing - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Table 19: Clinical Chemistry Market, United States, Volume (Units), Historic, 2010-2017
Table 20: Clinical Chemistry Market, United States, Volume (Units), Forecast, 2017-2024
Table 21: Blood Test Strips - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017
Table 22: Clinical Chemistry Analyzers Market, United States, Volume (Units), Historic, 2010-2017
Table 23: Enzyme Chemistry Reagents Market, United States, Volume (Units), Historic, 2010-2017
Table 24: Feces Tests - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017
Table 25: Substrates Market, United States, Volume (Units), Historic, 2010-2017
Table 26: Urine Testing - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017
Table 27: Blood Test Strips - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024
Table 28: Clinical Chemistry Analyzers Market, United States, Volume (Units), Forecast, 2017-2024
Table 29: Enzyme Chemistry Reagents Market, United States, Volume (Units), Forecast, 2017-2024
Table 30: Feces Tests - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024
Table 31: Substrates Market, United States, Volume (Units), Forecast, 2017-2024
Table 32: Urine Testing - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024
Table 33: Clinical Chemistry Market, United States, Average Price ($) Historic, 2010-2017
Table 34: Clinical Chemistry Market, United States, Average Price ($), Forecast, 2017-2024
Table 35: Clinical Chemistry Market, United States, Distribution Share by Revenue ($m), USD Constant, 2016-2017
Table 36: Clinical Chemistry Market, United States, Company Share by Revenue ($m), USD Constant, 2017
Table 37: Clinical Chemistry Market Pipeline Products
Table 38: BioIVT Acquires Qualyst Transporter Solutions
Table 39: Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025
Table 40: Rosetta Genomics Raises USD2 Million in Private Placement of Debentures and Warrants
Table 41: Thermo Fisher Scientific Raises USD750 Million in Public Offering of 4.1% Notes Due 2047
Table 42: Thermo Fisher Scientific Raises USD750 Million in Public Offering of 3.2% Notes Due 2027
Table 43: BioMarin Pharma Completes Underwriters Exercise of Over-Allotment Option of 0.599% Notes Due 2024 for USD45 Million
Table 44: Thermo Fisher Scientific Raises USD573.3 Million in Public Offering of Floating Rate Notes Due 2019
Table 45: Thermo Fisher Scientific Raises USD802.6 Million in Public Offering of 1.4% Notes Due 2026
Table 46: Thermo Fisher Scientific Raises USD802.6 Million in Public Offering of 1.95% Notes Due 2029
Table 47: Thermo Fisher Scientific Raises USD802.6 Million in Public Offering of 2.875% Notes Due 2037
Table 48: Becton, Dickinson to Raise USD1 Billion in Public Offering of 2.404% Notes Due 2020
Table 49: Becton, Dickinson to Raise USD1.8 Billion in Public Offering of 2.894% Notes Due 2022
Table 50: Becton, Dickinson to Raise USD500 Million in Public Offering of Floating Rate Notes Due 2022
Table 51: Becton, Dickinson to Raise USD1.75 Billion in Public Offering of 3.363% Notes Due 2024
Table 52: Becton, Dickinson to Raise USD2.4 Billion in Public Offering of 3.7% Notes Due 2027
Table 53: Becton, Dickinson to Raise USD1.5 Billion in Public Offering of 4.669% Notes Due 2047
Table 54: Becton, Dickinson to Raise USD788 Million in Public Offering of 0.368% Notes Due 2019
Table 55: AMAG Pharma Prices Public Offering of 3.25% Notes Due 2022 for USD300 Million
Table 56: Transgenomic Raises USD1.2 Million in Private Placement
Table 57: Thermo Fisher Scientific Prices Public Offering of 1.45% Notes Due 2027 for USD530 Million
Table 58: Becton Dickinson Prices Public Offering of 1% Notes Due 2022 for USD500 Million
Table 59: Becton Dickinson Prices Public Offering of 1.9% Notes Due 2026 for USD500 Million
Table 60: Abbott Labs Raises USD2.85 Billion in Public Offering of 2.35% Notes due 2019
Table 61: Abbott Labs Raises USD2.85 Billion in Public Offering of 2.9% Notes due 2021
Table 62: Abbott Labs Raises USD1.5 Billion in Public Offering of 3.4% Notes Due 2023
Table 63: Abbott Labs Raises USD3 Billion in Public Offering of 3.75% Notes due 2026
Table 64: Abbott Labs Raises USD1.65 Billion in Public Offering of 4.75% Notes due 2036
Table 65: Abbott Labs Raises USD3.25 Billion in Public Offering of 4.9% Notes due 2046
Table 66: Thermo Fisher Scientific Prices Public Offering of Shares for USD1.5 Billion
Table 67: Chembio Diagnostics to Raise up to USD21.2 Million in Public Offering of Shares
Table 68: Becton Dickinson Raises USD2.47 Billion in Public Offering of Shares
Table 69: Becton Dickinson Raises USD2.47 Billion in Public Offering of Depositary Shares
Table 70: International Isotopes Raises USD3.4 Million in Private Placement of Series C Preferred Stock
Table 71: Essex Woodlands Management Invests Additional USD15 Million in Metabolon
Table 72: SenGenix Raises USD6.3 Million in Financing
Table 73: CytoVas Raises USD0.1 Million in Venture Financing
Table 74: Ativa Medical Raises USD9.5 Million in Venture Financing
Table 75: Akonni Biosystems Raises USD4 Million in Venture Financing
Table 76: Ceres Nanosciences Raises USD3 Million in First Tranche of Series A Financing
Table 77: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
1.2 List of Figures
Figure 1: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Figure 2: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Figure 3: Blood Test Strips - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Figure 4: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Figure 5: Enzyme Chemistry Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Figure 6: Feces Tests - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Figure 7: Substrates Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Figure 8: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Figure 9: Urine Analysis Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Figure 10: Urine Testing - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Figure 11: Blood Test Strips - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Figure 12: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Figure 13: Enzyme Chemistry Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Figure 14: Feces Tests - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Figure 15: Substrates Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Figure 16: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Figure 17: Urine Analysis Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Figure 18: Urine Testing - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Figure 19: Clinical Chemistry Market, United States, Volume (Units), Historic, 2010-2017
Figure 20: Clinical Chemistry Market, United States, Volume (Units), Forecast, 2017-2024
Figure 21: Blood Test Strips - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017
Figure 22: Clinical Chemistry Analyzers Market, United States, Volume (Units), Historic, 2010-2017
Figure 23: Enzyme Chemistry Reagents Market, United States, Volume (Units), Historic, 2010-2017
Figure 24: Feces Tests - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017
Figure 25: Substrates Market, United States, Volume (Units), Historic, 2010-2017
Figure 26: Urine Testing - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017
Figure 27: Blood Test Strips - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024
Figure 28: Clinical Chemistry Analyzers Market, United States, Volume (Units), Forecast, 2017-2024
Figure 29: Enzyme Chemistry Reagents Market, United States, Volume (Units), Forecast, 2017-2024
Figure 30: Feces Tests - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024
Figure 31: Substrates Market, United States, Volume (Units), Forecast, 2017-2024
Figure 32: Urine Testing - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024
Figure 33: Clinical Chemistry Market, United States, Company Share (%) 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report